Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Clinical Calculator For Predicting Freedom From Recurrence After Resection Of Stage I-iii Colon Cancer In Patients With Microsatellite Instability.
  1. Home
  3. Clinical Calculator For Predicting Freedom From Recurrence After Resection Of Stage I-iii Colon Cancer In Patients With Microsatellite Instability.

Related Experiment Video

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239

Clinical Calculator for Predicting Freedom From Recurrence After Resection of Stage I-III Colon Cancer in Patients

Ayyuce Begum Bektas1, Lynn Hakki2, Asama Khan2

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.

JCO Clinical Cancer Informatics
|August 9, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

A new nomogram model accurately predicts recurrence-free survival in patients with microsatellite instability (MSI) colon cancer. This tool identifies high-risk individuals, aiding surveillance and clinical trial design for better outcomes.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

Related Experiment Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

Area of Science:

  • Oncology
  • Gastroenterology
  • Cancer Research

Background:

  • Patients with nonmetastatic microsatellite instability (MSI) colon cancer generally have a favorable prognosis.
  • However, specific high-risk subgroups within this population require better identification for tailored management.

Purpose of the Study:

  • To develop and validate a nomogram model for predicting freedom from recurrence (FFR) in patients with resected MSI colon cancer.
  • To create a clinical calculator to identify patients at high risk of recurrence.

Main Methods:

  • Retrospective analysis of data from 384 patients (training cohort) and 164 patients (validation cohort) with resected stage I-III MSI colon cancer.
  • Multivariable analysis identified significant predictors of recurrence, including T category and lymph node status.
  • Model performance was assessed using the concordance index (CI).

    • Main Results:

    • The nomogram model demonstrated robust predictive accuracy with a CI of 0.812 in the training cohort and 0.744 in the validation cohort.
    • The model outperformed the AJCC staging schema (CI 0.759) in the training cohort.
    • Advanced T category and number of positive lymph nodes were significant predictors of recurrence.

    Conclusions:

    • The developed nomogram effectively identifies patients with MSI colon cancer at high risk for recurrence.
    • This tool can inform personalized surveillance strategies and assist in the design of clinical trials for novel adjuvant therapies.
    • Accurate risk stratification is crucial for optimizing treatment and follow-up in MSI colon cancer.